Cobimetinib

Cobimetinib is a targeted cancer medication used mainly to treat advanced melanoma, a type of skin cancer. It works by blocking a specific protein called MEK, which helps cancer cells grow and divide. By inhibiting this protein, cobimetinib can slow or stop the progression of the disease. It is usually used in combination with other therapies, like immunotherapy, to improve treatment effectiveness. Cobimetinib is taken orally, in pill form, and patients are monitored by their healthcare team for side effects and response to the treatment.